CN1074292C - Cancer treating medicine capsule - Google Patents
Cancer treating medicine capsuleInfo
- Publication number
- CN1074292C CN1074292C CN99116479A CN99116479A CN1074292C CN 1074292 C CN1074292 C CN 1074292C CN 99116479 A CN99116479 A CN 99116479A CN 99116479 A CN99116479 A CN 99116479A CN 1074292 C CN1074292 C CN 1074292C
- Authority
- CN
- China
- Prior art keywords
- gram
- parts
- rhizoma
- capsule
- grams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to a cancer treating medicine capsule for treating cancer as a common frequently encountered disease. The cancer treating medicine capsule is prepared from a capsule and medicines in the capsule; the medicines of the cancer treating medicine capsule comprises ginseng, aweto, barbary wolfberry fruit, white paeony root, liquoric root, turtle shell, pangolin scale, indian iphigenia bulb, windpipe trachea, arisaema, bolbostemmae, rhizoma, danshen root, safflower, zedoary, common prism rhizome, vietnamese sophora root, barbat skullcap, dioscorea bulbifera, spreading hedyotis herb and musk, wherein the ginseng, the aweto, the barbary wolfberry fruit, the turtle shell and the pangolin scale are pulverized into fine powder and uniformly sieved; except for the musk, the rest medicines are boiled by water and extracted for two times; filtrates of the two times are merged and concentrated into thick paste; after the thick paste is mixed with the medicinal powder, the thick paste and the medicinal powder are placed in a baking box and dried; the thick paste and the medicinal powder are taken out, chilled and pulverized into fine powder; after the musk is uniformly mixed with the fine powder and respectively loaded in capsules after being finely pulverized. The present invention has the advantages of convenient administration, conspicuous curative effect and bright application prospect.
Description
The present invention relates to a kind of treatment cancer capsule for medicine.
Present various cancer has been common frdquently encountered disease, but the healing difficulty is very big, and people's healthy and life security in serious harm, and medical circle is being made great efforts head it off.The medicine of treatment cancer is a lot of at present, but effect is not good enough.Its basic reason is to catch at all, with symptomatic treatment.Therefrom medically say, entangle the not outer vital QI being weakened and pathogen being violent of its formation because of cancer, weakened body resistance then anti-evil machine level is low, forms the body of susceptible; The domination of pathogen then comprises poison Shengs, expectorant knot, blood stasis and the knot of materialize gathers.The position internal organs difference that its knot is poly-forms various cancerous protuberances.The rule of treatment of cancer is not outer sets upright eliminating evil two big rules so control.Can Chinese medicine and pharmacy be a big treasure-house, has the various affluent resources that coagulate difficult disease of treatment, utilize the principle of Chinese materia medica so, create a kind of effective treatment cancer new drug?
Purpose of the present invention just provides a kind of treatment cancer capsule for medicine (claiming to disappear the cancer recovering capsule again, as follows), to solve the treatment for cancer problem effectively.
The object of the present invention is achieved like this, principle according to the Chinese traditional treatment cancer, adopt active ingredient to constitute capsule through the processing of science compatibility, its active princlple adopts Radix Ginseng, Cordyceps, Fructus Lycii, the Radix Paeoniae Alba, Radix Glycyrrhizae to set upright, the enhancing body resistance against diseases is monarch drug in the side, Carapax Trionycis, Squama Manis, salty-cold soft tightly poly-with the abdominal mass knot that disappears, be ministerial drug in the side, Pseudobulbus Cremastrae Seu Pleiones, Rhizoma Paridis purify the blood branch vicious with the detumescence piece; Rhizoma Arisaematis, Rhizoma Bolbostematis energy vanishing sputum and dispelling knot; Radix Salviae Miltiorrhizae, Flos Carthami, rhizoma sparganic, Rhizoma Curcumae are with the dissipating blood stasis blood abdominal mass that disappears; Radix Sophorae Tonkinensis, Herba Scutellariae Barbatae, Dioscorea bulbifera L., Herba Hedyotidis Diffusae all have the effect that suppresses preferably and eliminate cancerous cell, are present the most frequently used Chinese medicine medicine for preventing; The Moschus row guide of scurrying to all medicines of having one's ideas straightened out is a messenger drug, and priming promotes the bigger effectiveness of his medicine performance to reach disease institute.All medicines share, and play supplementing QI and nourishing YIN altogether, strengthening the body resistance, the expectorant knot that looses, repercussive blood, separate vicious, the anticancer effect of subsiding a swelling.
Abundant raw material of the present invention, cost is low, science compatibility, effective percentage height, taking convenience, popularizing application prospect light.
Below in conjunction with the embodiment concrete condition the present invention is elaborated.
According to pathogenesis of cancer mechanism and compatibility requirement, treatment cancer capsule for medicine is made of capsule and interior medicine thereof, its medicine by:
6 parts of 4 parts of structure Fructus Lyciis of 10 parts of Cordyceps of Radix Ginseng
10 parts of 4 parts of Carapax Trionycis of 8 portions of Radix Glycyrrhizaes of the Radix Paeoniae Alba
12 parts of 8 parts of Rhizoma Paridis of 10 parts of Pseudobulbus Cremastrae Seu Pleioness of Squama Manis
12 parts of 8 parts of Radix Salviae Miltiorrhizaes of 6 parts of Rhizoma Bolbostematiss of Rhizoma Arisaematis
8 parts of 8 parts of rhizoma sparganic of 8 parts of Rhizoma Curcumae of Flos Carthami
8 parts of 12 portions of Dioscorea bulbifera L.es of 12 portions of Herba Scutellariae Barbataes of Radix Sophorae Tonkinensis
1 part in 12 parts of Moschus of Herba Hedyotidis Diffusae group or active drug, in component, Radix Ginseng, Cordyceps, Fructus Lycii, Carapax Trionycis, Squama Manis are ground into the 80-120 order fine powder mixing that sieves, flour extraction 90%.All the other medicines are except that Moschus, decocting boils carries secondary, merges secondary filtrate and is concentrated into the thick paste shape, and 60 ℃ are surveyed relative density is 1.29, paste-forming rate 7.6%, behind thick paste and the last medicated powder mixing, put in the baking oven 60-80 ℃ dry by the fire in, take out put cold, divide and be broken into fine powder, behind the Moschus porphyrize,, according to dosage divide the capsule of packing into the fine powder mix homogeneously.Composition of the present invention can be by the requirement of preparation amount, corresponding increase or minimizing.As make 1000, and the cancer recovering capsule that disappears of every heavy 0.45 gram, according to the component requirement, by:
Radix Ginseng 100 gram Cordyceps 40 gram Fructus Lycii 60 grams
The Radix Paeoniae Alba 80 gram Radix Glycyrrhizaes 40 gram Carapax Trionycis 100 grams
Squama Manis 100 Keshan Rhizoma sagittariae sagittifoliaes 80 gram Rhizoma Paridis 120 grams
Rhizoma Arisaematis 60 gram Rhizoma Bolbostematiss 80 gram Radix Salviae Miltiorrhizaes 120 grams
Flos Carthami 80 gram Rhizoma Curcumae 80 gram rhizoma sparganic 80 grams
Radix Sophorae Tonkinensis 120 gram Herba Scutellariae Barbataes 120 gram Dioscorea bulbifera L.es 80 grams
Herba Hedyotidis Diffusae 120 gram Moschus 10 grams, constitute medicine, Radix Ginseng, Cordyceps, Fructus Lycii, Carapax Trionycis, Squama Manis are ground into 80-120 order fine powder, powder delivery 360 grams, all the other medicines are except that Moschus, and water also boils twice, merge secondary filtrate and are concentrated into the thick paste shape, 60 ℃ are surveyed relative density is 1.29, get 96 gram thick pastes, add again in the fine powders of 360 grams, behind the mixing, put 60-80 ℃ of oven dry in the baking oven, cooling to divide is broken into 440 gram fine powders again, with the Moschus porphyrize, evenly adds in the fine powder, divide in the capsule of packing into to become 1000 every heavy 0.45 gram.Can be made into the capsule of other quantity and weight equally, on request.
This product is a capsule, and content is pale brown toner end, the hot perfume of gas, mildly bitter flavor, puckery.3 times on the oral one, each 4, warm water delivery service, contraindication in pregnancy, dry shady and cool place sealing is stored.Meet 9 pages of ministry standards of appendix of Chinese Pharmacopoeia nineteen ninety-five version fully through check product of the present invention, the medicine inspection of seeing Appendix report.Its function: supplementing QI and nourishing YIN, strengthening the body resistance, promoting blood circulation to remove stagnancy, separate vicious, anti-tumor.Can cure mainly: cancer, primary hepatocarcinoma disease are seen hepatic region twinge or distending pain, anorexia, and body is thin weak etc.
Following in conjunction with concrete clinical in former generation liver cancer treatment situation, as seen this has and has tangible creativeness and practical value.
Former generation hepatocarcinoma is meant from hepatocyte or the cytogenetic cancerous protuberance of stones in intrahepatic bile duct, is one of common malignant neoplasm.Be equivalent to the traditional Chinese medical science the liver rump, gather.Chinese and western medicine is to the no effect method of advanced liver cancer treatment at present, when making a definite diagnosis, Most patients belonged to late period, lose the surgical engine meeting, chemical therapy toxic side effect is big, is difficult to adhere to treatment, according to the principle of medical science basic theories " strengthening vital QI to eliminate pathogenic factors ", the Chinese medicine of the preparation cancer recovering capsule treatment primary hepatocarcinoma that disappears, and with western medicine contrast, obtained satisfactory effect, the result is as follows:
One, physical data: this group case 152 examples are divided into experimental group and matched group, experimental group 102 examples, matched group 50 examples, male 46 examples in experimental group 102 examples, women 56 examples at random; At minimum 20 years old of age, maximum 63 years old, the course of disease is the shortest 3 months, and was the longest 3 years.Matched group 50 examples, middle male 24 examples, woman 26 years old, at minimum 19 years old of age, maximum 63 years old, the course of disease is the shortest 3 months, and was the longest 3 years, learned by statistics for two groups and handled P>0.05, two group state of an illness basically identical, had comparability.
Two, case is selected
Get rid of other internal organs tumor person that is transferred to the liver, the clinical research guideline of the new Chinese medicine treatment primary hepatocarcinoma of working out in 1993 according to health ministry is established Chinese and western medicine diagnostic criteria and test case standard.
Three, Therapeutic Method
The experimental group patient all takes the cancer recovering capsule that disappears, and every day 3 times, each 4, two months is a course of treatment, and matched group is judged curative effect with fluorouracil+vincristine+cyclophosphamide medication at intermittence after 2 months.
Four, result
The cancer recovering capsule of finding to disappear in clinical is treated primary hepatocarcinoma, in mitigation symptoms, the quality of making the life better and aspect prolonging life cycle remarkable speciality is arranged, cancer is produced certain effect, as make cancer disappear, dwindle, stablize or slower development, not only control " disease ", and control " people ", curative effect is pressed new Chinese medicine clinical research guideline and is judged as follows:
1, controls back life cycle (controlling the back survival rate)
Life cycle | 6 months | 1 year | 2 years | 3 years | 4 years | 5 years | More than 5 years |
Experimental group (people) | 2 | 6 | 20 | ?30 | 20 | ?10 | 22 |
Matched group (people) | 3 | 10 | 10 | ?11 | 8 | 4 | 4 |
2, quality of life is improved situation: adopt the Karnofsky standards of grading
Classification | 100 | 90 | ?80 | 70 | 60 | 50 | 40 | ?30 | 20 | 10 | 0 |
Experimental group (people) | 30 | 20 | ?10 | 10 | 8 | 7 | 6 | 5 | 3 | 2 | 1 |
Matched group (people) | 0 | 2 | ?10 | 6 | 5 | 7 | 6 | 6 | 4 | 2 | 2 |
3, the focus objective indicator is improved situation
Situation | Alleviate fully | Part is alleviated | Stable | |||||
Experimental group (people) % | 50 | Account for 49% | 30 | Account for 29% | 20 | Account for 19.6% | 2 | Account for 1.96% |
Matched group (people) % | 1 | Account for 2% | 30 | Account for 60% | 15 | Account for 30% | 4 | Account for 8% |
The cancer that disappears as can be seen from the table health treatment group on average can improve survival rate more than 3.6 years to primary hepatocarcinoma, and matched group on average can improve more than 2.7 years, and the two has significant difference.Aspect improving the quality of living, comment part standard can on average improve 74.4 fens by Karnofsky after taking the cancer recovering capsule that disappears, matched group can on average improve 51.4 fens, the cancer that disappears recovering capsule effectiveness is apparently higher than matched group: aspect focus improves, the cancer that disappears health can make 49% patient alleviate fully, and matched group only accounts for 2%, and thus also as can be seen, the cancer that disappears recovering capsule has absolute advantages aspect relief of symptoms.
Other relevant situations are asked for an interview adnexa 1,2,3.
1, drug inspection statement;
2, quality standard rises and draws explanation;
3, model case.
Claims (2)
1, treatment cancer capsule for medicine is characterized in that: be by
6 parts of 4 parts of Fructus Lycii of 10 parts of Cordyceps of Radix Ginseng
10 parts of 4 parts of Carapax Trionycis of 8 portions of Radix Glycyrrhizaes of the Radix Paeoniae Alba
12 parts of 8 parts of Rhizoma Paridis of 10 parts of Pseudobulbus Cremastrae Seu Pleioness of Squama Manis
12 parts of 8 parts of Radix Salviae Miltiorrhizaes of 6 parts of Rhizoma Bolbostematiss of Rhizoma Arisaematis
8 parts of 8 parts of rhizoma sparganic of 8 parts of Rhizoma Curcumae of Flos Carthami
8 parts of 12 portions of Dioscorea bulbifera L.es of 12 portions of Herba Scutellariae Barbataes of Radix Sophorae Tonkinensis
1 part of composition of 12 parts of Moschus of Herba Hedyotidis Diffusae, wherein, it is 90% fine powder that Radix Ginseng, Cordyceps, Fructus Lycii, Carapax Trionycis, Squama Manis are ground into flour extraction, and all the other medicines are except that Moschus, and water also boils twice, merge secondary filtrate and be concentrated into 7.6% thick paste shape, dry behind thick paste and the medicated powder mixing, divide to be broken into fine powder, behind the Moschus porphyrize, with the fine powder mix homogeneously, according to dosage divide the capsule of packing into.
2, treatment cancer capsule for medicine according to claim 1, it is characterized in that by:
Radix Ginseng 100 gram Cordyceps 40 gram Fructus Lycii 60 grams
The Radix Paeoniae Alba 80 gram Radix Glycyrrhizaes 40 gram Carapax Trionycis 100 grams
Squama Manis 100 Keshan Rhizoma sagittariae sagittifoliaes 80 gram Rhizoma Paridis 120 grams
Rhizoma Arisaematis 60 gram Rhizoma Bolbostematiss 80 gram Radix Salviae Miltiorrhizaes 120 grams
Flos Carthami 80 gram Rhizoma Curcumae 80 gram rhizoma sparganic 80 grams
Radix Sophorae Tonkinensis 120 gram Herba Scutellariae Barbataes 120 gram Dioscorea bulbifera L.es 80 grams
Herba Hedyotidis Diffusae 120 gram Moschus 10 grams constitute medicine, Radix Ginseng, Cordyceps, Fructus Lycii, Carapax Trionycis, Squama Manis are pulverized or 360 gram 80-120 order fine powders, all the other medicines are except that Moschus, water also boils twice, merges secondary filtrate and is concentrated into 96 gram thick paste shapes, adds in the fine powder of 360 grams again, behind the mixing, drying in oven, cooling to divide is broken into 440 gram fine powders again, and the Moschus porphyrize evenly adds in the fine powder, divide in the capsule of packing into to become 1000 every heavy 0.45 gram.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN99116479A CN1074292C (en) | 1999-05-19 | 1999-05-19 | Cancer treating medicine capsule |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN99116479A CN1074292C (en) | 1999-05-19 | 1999-05-19 | Cancer treating medicine capsule |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1247757A CN1247757A (en) | 2000-03-22 |
CN1074292C true CN1074292C (en) | 2001-11-07 |
Family
ID=5279286
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN99116479A Expired - Fee Related CN1074292C (en) | 1999-05-19 | 1999-05-19 | Cancer treating medicine capsule |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1074292C (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1311862C (en) * | 2004-09-03 | 2007-04-25 | 曾隆江 | Medicine for treating cancer |
CN101953975B (en) * | 2010-09-30 | 2012-02-01 | 倪海清 | Oral Chinese medicinal herbal tablets for treating tumors and preparation method |
CN102198242B (en) * | 2011-06-06 | 2012-05-23 | 许从玉 | Traditional Chinese medicine composition for treating hysteromyoma |
CN109045246A (en) * | 2018-10-23 | 2018-12-21 | 柳士贤 | A kind of selenium-rich pill for cancer-eliminating for the treatment of cancer and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1157737A (en) * | 1996-10-24 | 1997-08-27 | 张文善 | ''Shanzhiai'' oral dosage |
CN1178110A (en) * | 1996-09-28 | 1998-04-08 | 熊学贤 | Medicine for lung cancer |
-
1999
- 1999-05-19 CN CN99116479A patent/CN1074292C/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1178110A (en) * | 1996-09-28 | 1998-04-08 | 熊学贤 | Medicine for lung cancer |
CN1157737A (en) * | 1996-10-24 | 1997-08-27 | 张文善 | ''Shanzhiai'' oral dosage |
Also Published As
Publication number | Publication date |
---|---|
CN1247757A (en) | 2000-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101041033A (en) | Chinese medicine for treating hepatitis B | |
CN103041317A (en) | Traditional Chinese medicine composition for treating tumors and preparation method thereof | |
CN102210844B (en) | Chinese medicinal composition for treating chronic hepatitis and preparation method thereof | |
CN101711848B (en) | Chinese medicinal composition capable of adjunctively treating tumour | |
CN1305515C (en) | Chinese medicinal powder and decoction composition for treating cancer | |
CN1074292C (en) | Cancer treating medicine capsule | |
CN101406594B (en) | Chinese medicine for treating tumor of lung | |
CN1302799C (en) | Oral Chinese medicinal composition for treating virus myocarditis | |
CN101979035A (en) | Medicament for treating gynecological abnormal leucorrhea | |
CN102205109B (en) | Chinese medicinal composition for treating rheumatism and application thereof | |
CN1053362C (en) | Baicaoshengshou oral liquor and its preparation | |
CN1269518C (en) | Compound medicine for treating tuberculosis and its preparing method | |
CN1190229C (en) | Medicine for curing hepatitis B | |
CN1059590C (en) | Medicine for blood generation and preparing method | |
CN111388564B (en) | Traditional Chinese medicine for treating bradyarrhythmia | |
CN100339093C (en) | Compound medicine for treating coronary heart disease and angina pectoris and its preparing process | |
CN1194717C (en) | Snake poison capsule for treating lung cancer and its preparation method | |
CN1183297A (en) | Katsutoxin pill for tumor and preparing method thereof | |
CN1086949C (en) | Chinese medicine for hepatitis B and its preparation | |
CN1253003A (en) | Compound graceful jassamine preparation | |
CN1352966A (en) | Medicine for treating tracheitis and asthma | |
CN1331995A (en) | Chinese medicine composition for treating lung cancer | |
CN1241633C (en) | Snake venom capsule for treating lymph cancer and its preparation method | |
CN1059111C (en) | Capsule of American ginseng and astragalus membranaceus | |
CN1117853A (en) | Traditional Chinese medicinal composite for curing angioma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |